Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University.

  • Authors : Makanut S; Division of Pulmonology, Department of Internal Medicine, Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand. Electronic address: .; Wangteeraprasert A

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effectsSARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2023 Jun 29; Vol. 41 (29), pp. 4335-4340. Date of Electronic Publication: 2023 Jun 05.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes.

  • Authors : Hu Y; Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 211198, PR China.; Wang Y

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Vaccine [Vaccine] 2023 May 02; Vol. 41 (18), pp. 3003-3010. Date of Electronic Publication: 2023 Mar 30.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C).

  • Authors : Perez MA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA USA; Children's Healthcare of Atlanta, Atlanta, GA USA.

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans pediatric multisystem inflammatory disease, COVID-19 relatedSARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2023 Apr 24; Vol. 41 (17), pp. 2743-2748. Date of Electronic Publication: 2023 Mar 15.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Vaccine [Vaccine] 2023 Mar 17; Vol. 41 (12), pp. 1925-1933. Date of Electronic Publication: 2023 Jan 23.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine.

  • Authors : Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Department of Infectious Diseases, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Electronic address: .

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunity, Cellular*

  • Source: Vaccine [Vaccine] 2023 Feb 24; Vol. 41 (9), pp. 1545-1549. Date of Electronic Publication: 2023 Jan 31.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.

  • Authors : Moscara L; Hygiene Unit - Interdisciplinary Department of Medicine; University of Bari 'Aldo Moro', Italy.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/adverse effects ; Influenza, Human*/Influenza, Human*/Influenza, Human*/prevention & controlCOVID-19 breakthrough infections

  • Source: Vaccine [Vaccine] 2023 Aug 31; Vol. 41 (38), pp. 5655-5661. Date of Electronic Publication: 2023 Aug 04.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individuals.

  • Authors : Kuzel TG; Division of Allergy and Immunology and Division of Gerontology, Department of Internal Medicine, Rush University Medical Center, Rush University, Chicago, IL, USA; Rush Medical College, Chicago, IL, USA.

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Vaccine [Vaccine] 2023 Jan 23; Vol. 41 (4), pp. 879-882. Date of Electronic Publication: 2022 Dec 24.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older.

  • Authors : Saiag E; Information and Operation Branch, Tel-Aviv Sourasky Medical Center, 6 Weizmann St., Tel-Aviv 6423906, Israel. Electronic address: .; Alcalay Y

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Immunogenicity, Vaccine*SARS-CoV-2 variants

  • Source: Vaccine [Vaccine] 2023 Jan 23; Vol. 41 (4), pp. 914-921. Date of Electronic Publication: 2022 Dec 21.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway.

  • Authors : Caspersen IH; Centre for Fertility and Health, Norwegian Institute of Public Health, Postbox 222 Skøyen, N-0213 Oslo, Norway. Electronic address: .; Juvet LK

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Female

  • Source: Vaccine [Vaccine] 2023 Jan 09; Vol. 41 (2), pp. 614-620. Date of Electronic Publication: 2022 Dec 02.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study.

  • Authors : Lim AH; Institute for Clinical Research, National Institutes of Health, Ministry of Health, Malaysia. Electronic address: .; Ab Rahman N

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Vaccine [Vaccine] 2022 Sep 16; Vol. 40 (39), pp. 5675-5682. Date of Electronic Publication: 2022 Aug 24.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×